Burch R M, Kyle D J
Nova Pharmaceutical Corporation, Baltimore, Maryland 21224.
Pharm Res. 1991 Feb;8(2):141-7. doi: 10.1023/a:1015819431855.
Mass receptor screening is capable of identifying drug candidates in large compound libraries. Our laboratory has developed a mass screening technology by standardizing assay protocols that can be transferred from receptor to receptor. The entire operation, from disbursement of compounds to data analysis, is computerized to handle vast numbers of experimental results. The success of this method depends upon strict definitions of compound activity, with rapid elimination of compounds that do not fulfill all criteria. Finally, we approach automation with caution. While certain items, such as automatic harvesters, are essential for high-throughput screening, much time can be spent optimizing gadgets instead of gathering data.
质谱受体筛选能够在大型化合物库中识别候选药物。我们实验室通过标准化检测方案开发了一种质谱筛选技术,该方案可在不同受体之间转移。从化合物分发到数据分析的整个操作过程均实现了计算机化,以处理大量实验结果。该方法的成功取决于对化合物活性的严格定义,要迅速淘汰不符合所有标准的化合物。最后,我们谨慎对待自动化。虽然某些设备,如自动收获仪,对于高通量筛选至关重要,但可能会花费大量时间优化这些设备而不是收集数据。